Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy
Kathrin Renner(University Hospital Regensburg), Marina Kreutz(University Hospital Regensburg), Ayse N. Menevse(Leibniz Association), Katrin Peter(University Hospital Regensburg), Matthias Fante(University Hospital Regensburg), Elisa A. Rozeman(The Netherlands Cancer Institute), Stephanie Faerber(University Hospital Regensburg), Christina Bruß(University Hospital Regensburg), Raquel Blazquez(University Hospital Regensburg), Mark Selby(Bristol-Myers Squibb (United States)), Tobias Bopp(Johannes Gutenberg University Mainz), Maria Landa(University of Regensburg), Toszka Bohn(Johannes Gutenberg University Mainz), William Roush(Scripps Research Institute), Ibtisam Marchiq(Centre National de la Recherche Scientifique), Gudrun E. Koehl, John L. Cleveland(Scripps Research Institute), Annette Schnell(University Hospital Regensburg), Eva Gottfried(University of Regensburg), Holger M. Becker(University of Kaiserslautern), Lisa Hacker(University Hospital Regensburg), Oscar Krijgsman(The Netherlands Cancer Institute), Christina Brummer(University Hospital Regensburg), Philipp Beckhove(University Hospital Regensburg), Sabine Amslinger(University of Regensburg), Katja Dettmer(University of California, Davis), Peter J. Oefner, Sarah Warren(Nanostring Technologies (United States)), Tobias Pukrop(University of Göttingen), Sven Arke Lang(American Institute of Biological Sciences), Stefanie Pektor(Johannes Gutenberg University Mainz), Katja Evert(University of Regensburg), Christian U. Blank(Oncode Institute), Katrin Singer(University Hospital Regensburg), Lisa Aigle(University Hospital Regensburg), Jacques Pouysségur(Institut de Recherche sur le Cancer et le Vieillissement de Nice), Nathalie Kauer(University Hospital Regensburg), Wolfgang Herr(University Hospital Regensburg), SuFey Ong(Nanostring Technologies (United States)), Peter J. Siska(Vanderbilt University), Sonja-Maria Decking(University Hospital Regensburg), Matthias Miederer(Johannes Gutenberg University Mainz)
Cited by 297
Related Papers
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
Mass spectrometry‐based metabolomics
|Mass Spectrometry Reviews|2006|2.2k
Right Portal Vein Ligation Combined With In Situ Splitting Induces Rapid Left Lateral Liver Lobe Hypertrophy Enabling 2-Staged Extended Right Hepatic Resection in Small-for-Size Settings
|Annals of Surgery|2012|1.3k
Cyclin D1 Expression Is Regulated Positively by the p42/p44 and Negatively by the p38/HOG Pathway
|Journal of Biological Chemistry|1996|1.2k
Targeting lactate metabolism for cancer therapeutics
|Journal of Clinical Investigation|2013|1.2k